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Abstract
Propionic acidemia is an inborn error of metabolism caused by deficiency of the mitochondrial enzyme propionyl-
CoA carboxylase. Sensorineural deafness and severe hearing loss have been described as long-term complications
of this disease, however, the mechanism has not yet been elucidated. We have recently shown by patch clamping
experiments and Western blots that acute and chronic effects of accumulating metabolites such as propionic acid,
propionylcarnitine and methylcitrate on the KvLQT1/KCNE1 channel complex cause long QT syndrome in patients
with propionic acidemia by inhibition of K+ flow via this channel. The same KvLQT1/KCNE1 channel complex is
expressed in the inner ear and essential for luminal potassium secretion into the endolymphatic space. A disruption
of this K+ flow results in sensorineural hearing loss or deafness. It can be assumed that acute and chronic effects of
accumulating metabolites on the KvLQT1/KCNE1 channel protein may similarly cause the hearing impairment of
patients with propionic acidemia.
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Propionic acidemia (PA) is an inborn error of metabol-
ism caused by deficiency of the mitochondrial enzyme
propionyl-CoA carboxylase. This enzyme converts
propionyl-CoA to D-methylmalonyl-CoA and is involved
in the metabolism of branched-chain amino acids, odd-
numbered fatty acids, cholesterol side chains, thymine,
and uracil [1]. Patients with PA are prone to acute life-
threatening metabolic decompensations with severe
metabolic acidosis and hyperammonemia, and most
affected children already present with symptoms during
the neonatal period. With progression of the disease,
long-term complications involving the neurological,
cardiological, hematological, immunological and gastro-
intestinal system are common [2]. One of the main
cardiological problems is the development of an ac-
quired long QT syndrome (LQTS), which can be found
in up to 70% of patients beyond childhood and puts
patients at risk for potentially lethal ventricular arrhythmia
[2, 3]. Among the neurological complications, sensori-
neural hearing impairment has been reported in several
patients with PA [2, 4, 5]. In a study with 55 PA patients
from Germany, Switzerland and Austria, hearing loss was
apparent in 13% of the patients [2]. Similarly, Brosch et al.
described 4 patients with PA and sensorineural deafness
or severe hearing loss [5]. Mutation analyses of the PCCA
and PCCB genes, encoding the two subunits of the
propionyl-CoA carboxylase, have been performed in the
families of these patients to elucidate whether mutations
primarily responsible for PA could also be the underlying
cause for a genetic form of deafness. Brosch et al.
concluded that no connection can be assumed between
the mutations found in the patients and the severe sen-
sorineural hearing loss. So far, the mechanism of hearing
impairment in PA has not yet been elucidated. However,
our studies on the effects of metabolites, that typically
accumulate in body fluids of patients with PA, on the
KvLQT1/KCNE1 channel give new insights on the
possible mechanism of hearing loss associated with
this disorder.
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The same combination of LQTS and sensorineural
deafness as seen in PA patients is also found in Jervell
and Lange-Nielsen syndrome. This genetic disorder with
an autosomal recessive inheritance is characterized by
congenital LQTS with syncopal attacks due to ventricu-
lar arrhythmias and congenital profound bilateral sen-
sorineural hearing loss [6]. It is caused by mutations in
either the KCNQ1 or KCNE1 genes, encoding the alpha
and beta subunits (KvLQT1 and KCNE1/minK) of a
potassium channel carrying the so-called delayed recti-
fier potassium current IKs [7]. About 90% of cases of
Jervell and Lange-Nielsen syndrome are caused by muta-
tions in the KCNQ1 gene [8–10]. The KvLQT1/KCNE1
voltage-gated potassium channel is expressed not only in
cardiomyocytes but also in cells of the stria vascularis of
the inner ear [11, 12]. In the heart, this channel is essen-
tial for cardiac repolarization, and mutations in either
the KCNQ1 or KCNE1 gene lead to a reduction of the
IKs current and therefore prolongation of the action
potential [13, 14]. In the inner ear, this channel enables
luminal secretion of K+ into the endolymphatic space
[15, 16]. A disruption of this K+ flow results in sensori-
neural hearing loss or deafness. We therefore
hypothesize that sensorineural hearing loss and long QT
syndrome seen in propionic acidemia share a common
pathogenic mechanism.
We have recently shown that the acquired LQTS ob-
served in patients with PA is due to acute and chronic
effects of accumulating metabolites on the KvLQT1/
KCNE1 channel and its function. Namely, propionic
acid, propionylcarnitine and methylcitrate, the key
metabolites accumulating in PA, have acute blocking
effects on this potassium channel and thereby reduce IKs
current and prolong action potential duration (Fig. 1)
[17]. Additionally, the expression of KvLQT1 is altered
in the presence of these metabolites: Chronic exposure
(24 h) to propionylcarnitine and methylcitrate decreases
KvLQT1 expression - in line with the acute IKs-blocking
effects [17]. We hypothesize that the hearing impairment
of patients with PA may be caused by the same mecha-
nisms that lead to acquired LQTS (Fig. 2). In the inner
ear the KvLQT1/KCNE1 channel is critical for the pro-
duction and homeostasis of the endolymph, the
potassium-rich fluid surrounding the neuroepithelium of
the inner ear [6]: Potassium ions are absorbed from the
perilymph by basal cells, further transported through
gap junctions to intrastrial fluids, and then pumped into
intermediate cells through the Kir4.1 potassium channel,
a
b
Fig. 1 a. Propionic acid effects on IKs current in KCNQ1/KCNE1-CHO cells. Representative whole cell current traces at baseline, after the
application of PA (5 mM, blue), and after brief wash-out (grey), demonstrating an acute reduction of IKs by 50%. Voltage clamp protocol is shown
in the inset. b. Propionic acid effects on action potential in human iPSC-CMs. Superimposed representative AP traces at baseline and after PA
(5 mM, blue), indicating an AP-prolongation
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which creates a high intracellular potassium concentration
[6]. The consequential concentration gradient between
intrastrial fluid and intermediate cells generates the endo-
cochlear potential [18]. From the intrastrial fluid, potas-
sium ions are transported across the basolateral membrane
of marginal strial cells by the Na+/K+-ATPase and Na+/K
+/Cl− cotransporter [19–22]. Finally, K+ crosses the apical
membrane through the KCNQ1/KCNE1 potassium chan-
nel and is secreted into the endolymph [11, 19]. The endo-
cochlear potential is essential for audition [20] and
disturbances of the endocochlear potential can lead to the
immediate loss of hearing, which may be irreversible [23].
In addition to altered KCNQ1/KCNE1 channel func-
tion, histopathological changes in the inner ear - causa-
tively linked to the altered KCNQ1/KCNE1 function -
have been described in patients with Jervell and Lange-
Nielsen syndrome: As early as in the 1960ies, temporal
bone histology has been investigated and profound his-
topathologic abnormalities including the collapse of
Reissner’s membrane and membranes surrounding the
saccule, utricle and ampullae were found, resulting in
the obliteration of the scala media and endolymphatic
compartments of the vestibular end organs [6, 24, 25].
KCNQ1 knockout mice similarly exhibit histopathologic
findings that are comparable to those reported in pa-
tients with Jervell and Lange-Nielsen syndrome with
marked atrophy of the stria vascularis, contraction of the
endolymphatic compartments, collapse and adhesion of
surrounding membranes, complete degeneration of the
organ of Corti and an associated degeneration of the spiral
ganglion [26]. These histopathological changes underline
the importance of the KvLQT1/KCNE1 channel for the
structural integrity of the inner ear.
Due to the critical role of the KvLQT1/KCNE1 channel,
it is well conceivable that blocking effects of circulating
metabolites of propionic acid on the IKs current as well as
effects on the expression of the channel subunits may
have severe consequences and lead to hearing impairment
or even deafness. These mechanisms are likely to be the
cause of hearing impairment in patients with PA.
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